LEADER 00948nam0-2200301---450- 001 990008311850403321 005 20100427133056.0 035 $a000831185 035 $aFED01000831185 035 $a(Aleph)000831185FED01 035 $a000831185 100 $a20060412d1967----km-y0itay50------ba 101 0 $aeng 102 $aUS 105 $aa-------001yy 200 1 $aDesign of active-site-directed irreversible enzyme inhibitors$ethe organic chemistry of the enzymic active-site$fB. R. Baker 210 $aNew York$cJohn Wiley and Sons$d1967 215 $aXIII, 325 p.$cill.$d23 cm 610 0 $aEnzimi 676 $a574.1925 700 1$aBaker,$bBernard Randall$f<1915- >$0320567 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990008311850403321 952 $a80 VII B 83 CFT (4)$bCFT 5291$fFFABC 959 $aFFABC 996 $aDesign of active-site-directed irreversible enzyme inhibitors$9745515 997 $aUNINA LEADER 01019nam--2200361---450- 001 990001855960203316 005 20091007143647.0 035 $a000185596 035 $aUSA01000185596 035 $a(ALEPH)000185596USA01 035 $a000185596 100 $a20040715d1971----km-y0itay0103----ba 101 $aeng 102 $aGB 105 $a||||||||001yy 200 1 $a<> degradation of the academic dogma$fby Robert Nisbet 210 $aLondon$cHeinemann$d1971 215 $a259 p.$d21 cm 410 0$12001 454 1$12001 461 1$1001-------$12001 676 $a378.73 700 1$aNISBET,$bRobert A.$0142531 801 0$aIT$bsalbc$gISBD 912 $a990001855960203316 951 $a378.73 NIS 1 (IX A 334)$b44585 L.M.$cIX A$d00245332 959 $aBK 969 $aECO 979 $aSIAV6$b10$c20040715$lUSA01$h1824 979 $aRSIAV3$b90$c20091001$lUSA01$h1631 979 $aRSIAV3$b90$c20091007$lUSA01$h1436 996 $aDegradation of the academic dogma$9956081 997 $aUNISA